Cetera Trust Company’s Novartis NVS Stock Holding History

Cetera Trust Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510K	Sell	3,252 -100	-3%	-$15K	0.26%	74
2026 Q1	$512K	Sell	3,352 -100	-3%	-$15.3K	0.29%	67
2025 Q4	$476K	Sell	3,452 -100	-3%	-$13.1K	0.25%	73
2025 Q3	$456K	Sell	3,552 -175	-5%	-$21.4K	0.26%	71
2025 Q2	$451K	Buy	3,727 +100	+3%	+$11.3K	0.27%	71
2025 Q1	$404K	Hold	3,627	–	–	0.26%	65
2024 Q4	$353K	Sell	3,627 -60	-2%	-$6.4K	0.23%	80
2024 Q3	$424K	Hold	3,687	–	–	0.26%	70
2024 Q2	$393K	Hold	3,687	–	–	0.25%	65
2024 Q1	$357K	Sell	3,687 -200	-5%	-$20.5K	0.21%	76
2023 Q4	$392K	Buy	+3,887	New	+$375K	0.24%	68

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cetera Trust Company's NVS Position: Q2 2026 in Review

Cetera Trust Company reduced its Novartis (NVS) stake by 3% in Q2 2026, selling an estimated $15K and leaving 3,252 shares worth $510K. The position accounts for 0.26% of the portfolio, ranked #74.

Cetera Trust Company first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $512K in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Cetera Trust Company held 3,252 shares of Novartis worth $510K as of Q2 2026.
Cetera Trust Company sold 100 Novartis shares in Q2 2026, an estimated $15K.
Novartis made up 0.26% of Cetera Trust Company's portfolio in Q2 2026, its #74 holding.
Cetera Trust Company first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
Cetera Trust Company's Novartis position peaked at $512K in Q1 2026.
1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.